313 related articles for article (PubMed ID: 14747532)
1. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.
Nakayama T; Hieshima K; Nagakubo D; Sato E; Nakayama M; Kawa K; Yoshie O
J Virol; 2004 Feb; 78(4):1665-74. PubMed ID: 14747532
[TBL] [Abstract][Full Text] [Related]
2. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder.
Takegawa S; Jin Z; Nakayama T; Oyama T; Hieshima K; Nagakubo D; Shirakawa AK; Tsuzuki T; Nakamura S; Yoshie O
Cancer Sci; 2008 Feb; 99(2):296-302. PubMed ID: 18271928
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22.
Hammad H; Smits HH; Ratajczak C; Nithiananthan A; Wierenga EA; Stewart GA; Jacquet A; Tonnel AB; Pestel J
Eur Cytokine Netw; 2003; 14(4):219-28. PubMed ID: 14715413
[TBL] [Abstract][Full Text] [Related]
4. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.
McIlroy A; Caron G; Blanchard S; Frémaux I; Duluc D; Delneste Y; Chevailler A; Jeannin P
Immunology; 2006 Apr; 117(4):507-16. PubMed ID: 16556265
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.
Kanamori M; Watanabe S; Honma R; Kuroda M; Imai S; Takada K; Yamamoto N; Nishiyama Y; Kawaguchi Y
J Virol; 2004 Apr; 78(8):3984-93. PubMed ID: 15047814
[TBL] [Abstract][Full Text] [Related]
6. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity.
Ying S; O'Connor B; Ratoff J; Meng Q; Mallett K; Cousins D; Robinson D; Zhang G; Zhao J; Lee TH; Corrigan C
J Immunol; 2005 Jun; 174(12):8183-90. PubMed ID: 15944327
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
Horikawa T; Nakayama T; Hikita I; Yamada H; Fujisawa R; Bito T; Harada S; Fukunaga A; Chantry D; Gray PW; Morita A; Suzuki R; Tezuka T; Ichihashi M; Yoshie O
Int Immunol; 2002 Jul; 14(7):767-73. PubMed ID: 12096036
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells.
Iellem A; Colantonio L; Bhakta S; Sozzani S; Mantovani A; Sinigaglia F; D'Ambrosio D
Eur J Immunol; 2000 Apr; 30(4):1030-9. PubMed ID: 10760790
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
Osabe M; Tajika T; Tohkin M
J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
[TBL] [Abstract][Full Text] [Related]
10. EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.
Jorapur A; Marshall LA; Jacobson S; Xu M; Marubayashi S; Zibinsky M; Hu DX; Robles O; Jackson JJ; Baloche V; Busson P; Wustrow D; Brockstedt DG; Talay O; Kassner PD; Cutler G
PLoS Pathog; 2022 Jan; 18(1):e1010200. PubMed ID: 35025968
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes.
Jeong SI; Choi BM; Jang SI
Arch Pharm Res; 2010 Nov; 33(11):1867-76. PubMed ID: 21116791
[TBL] [Abstract][Full Text] [Related]
12. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
13. (+)-Nootkatone inhibits tumor necrosis factor α/interferon γ-induced production of chemokines in HaCaT cells.
Choi HJ; Lee JH; Jung YS
Biochem Biophys Res Commun; 2014 May; 447(2):278-84. PubMed ID: 24704449
[TBL] [Abstract][Full Text] [Related]
14. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
Belperio JA; Dy M; Murray L; Burdick MD; Xue YY; Strieter RM; Keane MP
J Immunol; 2004 Oct; 173(7):4692-8. PubMed ID: 15383605
[TBL] [Abstract][Full Text] [Related]
15. The role of chemokines in Hodgkin's disease.
Teruya-Feldstein J; Tosato G; Jaffe ES
Leuk Lymphoma; 2000 Jul; 38(3-4):363-71. PubMed ID: 10830743
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.
Higuchi T; Matsuo K; Hashida Y; Kitahata K; Ujihara T; Taniguchi A; Yoshie O; Nakayama T; Daibata M
Cancer Lett; 2019 Jul; 453():184-192. PubMed ID: 30953706
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
18. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
20. Production of TARC and MDC by naive T cells in asthmatic patients.
Hirata H; Arima M; Cheng G; Honda K; Fukushima F; Yoshida N; Eda F; Fukuda T
J Clin Immunol; 2003 Jan; 23(1):34-45. PubMed ID: 12645858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
